These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36941001)

  • 1. A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administration.
    Beiler B; Vigneron J; D'Huart E; Demoré B
    Eur J Hosp Pharm; 2023 Mar; ():. PubMed ID: 36941001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First international database of research teams in stability and compatibility of medications: An additional function in the Stabilis
    D'Huart E; Vigneron J; Gindre I; Lider P; Demoré B
    Ann Pharm Fr; 2018 Nov; 76(6):436-443. PubMed ID: 30243469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug compatibility in neonatal intensive care units: gaps in knowledge and discordances.
    Fernández-Peña A; Katsumiti A; De Basagoiti A; Castaño M; Ros G; Sautua S; De Miguel M; Campino A
    Eur J Pediatr; 2021 Jul; 180(7):2305-2313. PubMed ID: 33738517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of binary, ternary and quaternary mixtures for induction and maintenance of opioid free anesthesia.
    Tauste-Hernández B; Cortiñas-Sáenz M; Fernández-Ginés FD; Expósito-López JM
    Farm Hosp; 2021 Apr; 45(3):135-141. PubMed ID: 33941057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review.
    Castells Lao G; Rodríguez Reyes M; Roura Turet J; Prat Dot M; Soy Muner D; López Cabezas C
    Med Intensiva (Engl Ed); 2020 Mar; 44(2):80-87. PubMed ID: 30262380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of Y-Site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
    Lessard JJ; Caron E; Schérer H; Forest JM; Leclair G
    Hosp Pharm; 2020 Oct; 55(5):332-337. PubMed ID: 32999503
    [No Abstract]   [Full Text] [Related]  

  • 8. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 9. A new method to obtain and present complete information on the compatibility: study of its validity for eight binary mixtures of morphine with drugs frequently used in palliative care.
    Vermeire A; Remon JP; Schrijvers D; Demeulenaere P
    Palliat Med; 2002 Sep; 16(5):417-24. PubMed ID: 12380660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
    De Basagoiti A; Katsumiti A; Abascal S; Bustinza A; López-Giménez LR; Pascual P; De Miguel M; Campino A
    Eur J Pediatr; 2021 Apr; 180(4):1169-1176. PubMed ID: 33128625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated Y-site compatibility of atosiban acetate with selected intravenous drugs.
    Jiménez-Lozano I; Larrosa-García M; Boix-Montañés A; Bautista SC; Poy MJC
    Eur J Obstet Gynecol Reprod Biol; 2022 Aug; 275():106-109. PubMed ID: 35779331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures.
    Foushee JA; Meredith P; Fox LM; Grace E
    Int J Pharm Compd; 2016; 20(4):328-332. PubMed ID: 28333677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration.
    Foushee JA; Fox LM; Gormley LR; Lineberger MS
    Am J Health Syst Pharm; 2015 Mar; 72(6):483-6. PubMed ID: 25736944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Y-site administration of electrolyte solutions and injectable acetaminophen-A physical compatibility study with combinations frequently used in pediatric intensive care and anesthesia.
    Kleinlein M; Marschler S; Neininger MP; Hoeckel M; Bertsche T
    Paediatr Anaesth; 2023 Jan; 33(1):69-78. PubMed ID: 36214581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PharmDE: A new expert system for drug-excipient compatibility evaluation.
    Wang N; Sun H; Dong J; Ouyang D
    Int J Pharm; 2021 Sep; 607():120962. PubMed ID: 34339812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical compatibility of pentoxifylline and intravenous medications.
    Senarathna SMDKG; Strunk T; Petrovski M; Batty KT
    Arch Dis Child; 2019 Mar; 104(3):292-295. PubMed ID: 30472662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of tools to prevent drug incompatibilities in paediatric and neonatal intensive care units.
    De Giorgi I; Guignard B; Fonzo-Christe C; Bonnabry P
    Pharm World Sci; 2010 Aug; 32(4):520-9. PubMed ID: 20556656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of a Compatibility Chart for Continuous Infusions in the Intensive Care Unit.
    Kondo M; Tanaka C; Tagami T; Nagano M; Sugaya K; Tagui N; Kaneko J; Kudo S; Kuno M; Unemoto K; Takase H
    J Nippon Med Sch; 2022; 89(2):227-232. PubMed ID: 35545550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.